Grant: Canada Research Chairs
University of Toronto
$100,000.00
Cognitive Neuroscience
FY 2021-22
Summary
Early detection of Alzheimer¿s disease (AD) is essential, as treatments will be effective only before irreversible brain damage has occurred. Dr. Barense will apply recent neuroscience discoveries to develop sensitive markers for preclinical AD. Unlike other methods requiring a lumbar puncture or exposure to radiation, her measures are non-invasive. Thus, they can be administered repeatedly to asymptomatic individuals, enabling screening more of the population. Second, she will provide an effective, inexpensive, and non-invasive Digital Memory Augmentation device that externally mimics AD-compromised brain function. With her improved early detection measures, she will administer this intervention when it will be most effective.
Program
Canada Research Chairs
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
CRC-2019-00037
Name nom
Barense, Morgan
Department département
Psychology - University of Toronto
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2019
Award amount
100000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
6300
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Psychology
Research subject fr
Psychologie
Installment
inst:3-1
Partie
1
Nb partie
3
Application title
Cognitive Neuroscience
Keyword
NSERC
Application summary
Early detection of Alzheimer¿s disease (AD) is essential, as treatments will be effective only before irreversible brain damage has occurred. Dr. Barense will apply recent neuroscience discoveries to develop sensitive markers for preclinical AD. Unlike other methods requiring a lumbar puncture or exposure to radiation, her measures are non-invasive. Thus, they can be administered repeatedly to asymptomatic individuals, enabling screening more of the population. Second, she will provide an effective, inexpensive, and non-invasive Digital Memory Augmentation device that externally mimics AD-compromised brain function. With her improved early detection measures, she will administer this intervention when it will be most effective.